BioSpace News Archive

Exactech Announces Successful First Revision Knee Replacement Surgery With Truliant® Instrumentation

Orthopaedic surgeons will have a chance to experience the Truliant primary and revision systems through live mechanical demonstrations Nov. 2-5 at the American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting, Booth #908 in Dallas, Texas.

November 1, 2017
·
2 min read
Drug Development

Innovation Pharmaceuticals Phase IIb Psoriasis Study On-Track for Completion in December 2017; Company a Sponsor at Upcoming Symposium on Hidradenitis Suppurativa

The Company’s Phase 2b clinical trial of Prurisol, enrolling a total of 199 patients, remains on-track for completion in December.

November 1, 2017
·
8 min read
Business

Cambrex to Announce Third Quarter 2017 Financial Results on November 7, 2017

The Company will host a conference call to discuss the financial results.

November 1, 2017
·
1 min read
Business

DiaMedica Announces Dr. Robert Stanton as Scientific Advisor for Upcoming Chronic Kidney Disease Trials

Stanton will serve on DiaMedica’s Kidney Scientific Advisory Board.

November 1, 2017
·
3 min read
FDA

Avinger Receives 510(k) Clearance for Design Modifications to Enhance Performance of Pantheris Image-Guided Atherectomy Device

The 510(k) submission covered a series of non-significant design changes already incorporated into commercial products and previously documented as letters to file.

November 1, 2017
·
2 min read
Bio NC

CALQUENCE (Acalabrutinib) Approved for Previously-Treated Mantle Cell Lymphoma, Available for Order at Biologics, Inc.

CALQUENCE is a highly selective orally available potent inhibitor of Bruton’s tyrosine kinase (BTK).

November 1, 2017
·
4 min read
Business

Aduro Biotech Reports Third Quarter 2017 Financial Results

Net loss for the third quarter of 2017 was $24.5 million, or $0.33 per share.

November 1, 2017
·
9 min read
Genetown

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The employees received, in the aggregate, options to purchase 32,250 shares of Sarepta’s common stock.

November 1, 2017
·
1 min read
Business

Prothena to Report Third Quarter 2017 Financial Results on November 7

Consistent with past practice, the Company will not be conducting a conference call in conjunction with this financial results release on November 7.

November 1, 2017
·
1 min read
Business

TRACON to Report Third Quarter Company Highlights and Financial Results on November 7, 2017

In addition, management will host a conference call to provide an update on corporate activities and discuss the quarterly financial results.

November 1, 2017
·
1 min read